9Rasmussen SA, Eisen JL. The epidemiological and dinical features of obsessive-compulsive disorder. Jenike MA, editor. The Psychiatric Clinics of North America Obsessional Disorders[M]. vol. 15. Chicago W. B. Saunders Company, Harcourt Brace Jovanovich, Inc, 1992: 743- 758.
10Sasson Y, Zohar J, Chopra M, et al. Epidemiology of Obsessive compulsive disorder: a world view[J]. J Clin Psychiatry , 1997, 58(Suppl 12):7-10.
3Ehrt U, Aarsland D. Psychiatric aspects of Parkinson's disease[J]. Curr Opin Psychiatry,2005,18(3) ~ 335-341.
4Han D, Wang EC. Remission from depression: a review of venlafaxine clinical and economic evidence[J~. Pharmacol E- conomics, 2005, 23(6):567.
5Steketee G. Disability and family burden in obsessive-compul sive disorder[J].can J Psychiartry, 1997,42(9) :919-928.
6Hollander E, Bienstock CA, Koran LM, et al. refractory obsessive computsive disorder:state-of - the- art treatment[J]. J elin Psychiatry, 2002,63(Suppl 6) :S20-S29.
7Saxena S, Brody AL, Schwartz JM, et al. Neuroimaging and frontal-suhcortical circuitry in obsessive-compulsive disorder [J]. Br J Psychiatry, 1998,35(Suppl): S26-S37.
8Rauch SL. Neuroimaging and neurocircuitry models pertaining to the neurosurgical treatment of psychiatric disorders [J]. Neurosurg Clin N Am, 2003,14(2) :213-223.
9Lopes AC,Mathis ME, Canteras MM, et al. Update on neuro- surgical treatment for obsessive compulsive disorder[J]. Rev Bras Psiquiatr, 2004, 26(1) :62-66.
